Description
DELIVERY ORDER MATHER RADIOPHARMACEUTICALS - ADD AN ALTERNATE ITEM AS A SUBSTITUTE WHEN THE PRIMARY ITEM IS UNAVAILABLE.
Base award description: DELIVERY ORDER MATHER RADIOPHARMACEUTICALS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-12-31+$378,282= $378,282
- Mod P000012025-04-22+$0= $378,282
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-12-31 | +$378,282 | $378,282 | DELIVERY ORDER MATHER RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-04-22 | +$0 | $378,282 | DELIVERY ORDER MATHER RADIOPHARMACEUTICALS - ADD AN ALTERNATE ITEM AS A SUBSTITUTE WHEN THE PRIMARY ITEM IS UN… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UA3GDUKRYSM5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626P0728 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $839,629 | FY2026 |
| 36C24526N0404 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $510,182 | FY2026 |
| 36C26126N0371 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $250,075 | FY2026 |
| 36C26226N0409 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $1,561,204 | FY2026 |
| 36C26226N0410 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $752,000 | FY2026 |
| 36C25226P0239 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $303,486 | FY2026 |
Other recipients under 6550 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126N0364 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $112,848 | FY2026 |
| 36C26126P0448 | ROCHE DIAGNOSTICS CORPORATION | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $120,976 | FY2026 |
| 36C26126P0353 | HEMOSONICS, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $82,300 | FY2026 |
| 36C26126F0102 | WERFEN USA LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $79,671 | FY2026 |
| 36C26126N0128 | CEPHEID | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $1,084,961 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26125N0286_3600_36C26125D0024_3600 · retrieved 2026-09-26.